While several RP genes displayed pro-oncogenic effects and resulted in increased proliferation, other RP genes consistently exhibited negative dysregulation across cancers, which thereby acted directly or indirectly as tumor suppressors. This evidence concerns the gene BLOC1S3 and cancer.